Agoracom: Small Cap Investment - Awakn Life Sciences Corp. - Discussion Forum

Biotech Company With Clinical Operations Developing Psychedelic Medicine To Treat Addiction

First 3 UK Clinics Opened In 2021, Targeting 20 Clinics By 2024 ~$100M In Revenue

Free

List Message View

Thread Message View

Message Title

Rating

Author / Date

Jan 02, 2024 09:36AM

Awakn Life Sciences Secures Funding to Expand Nordic Commercial Operations

Oct 25, 2022 07:30AM

END OF DAY ALERT: Awakn Life Sciences (AWKN: NEO) (AWKNF: OTCQB) Up 11% On 8K Shares

Sep 30, 2022 04:00PM

Awakn Life Sciences Reports Strong Q2 2022 Results

Sep 15, 2022 07:30AM

Awakn Life Sciences Signs Drug Development Agreement with Catalent for Zydis(R) Technology (An Orally Disintegrating Tablet) to ...

Sep 12, 2022 07:30AM

END OF DAY ALERT: Awakn Life Sciences (AWKN: NEO) (AWKNF: OTCQB) Up 18% On 50K SHARES

Aug 30, 2022 04:36PM

Awakn Life Sciences Signs Agreement with a Leading Drug Development Company to Deepen IP Moat for Its Lead Program

Aug 25, 2022 07:30AM

END OF DAY ALERT: Awakn Life Sciences (AWKN: NEO) (AWKNF: OTCQB) Up 11% On 63K SHARES

Aug 18, 2022 04:38PM

Awakn Life Sciences Signs Second Licensing Partnership Agreement and Expands Commercial Operations Into Canada

Aug 18, 2022 07:45AM

END OF DAY ALERT: Awakn Life Sciences (AWKN: NEO) (AWKNF: OTCQB) Up 12% On 23K SHARES

Aug 17, 2022 04:39PM

END OF DAY ALERT: Awakn Life Sciences (AWKN: NEO) (AWKNF: OTCQB) Up 17% On 134K SHARES

Aug 15, 2022 04:20PM

Awakn Life Sciences Expands Commercial Operations into the U.S. - First Licensing Partnership Agreement with Revitalist

Aug 15, 2022 09:00AM

END OF DAY ALERT: Awakn Life Sciences (AWKN: NEO) (AWKNF: OTCQB) Up 33% On 69K SHARES

Jul 20, 2022 04:00PM

Re: Awakn Life Sciences' Phase III Trial Approved for Approximately CA$2.5 Million Funding from UK State Covering 66% of Costs

Jul 20, 2022 08:55AM

Awakn Life Sciences' Phase III Trial Approved for Approximately CA$2.5 Million Funding from UK State Covering 66% of Costs

Jul 20, 2022 08:24AM

Re: Awakn Life Sciences Appoints UK Leader in Addictions Psychiatry, Dr. Arun Dhandayudham, as Chief Medical Officer

Jul 18, 2022 02:50AM

Re: Awakn Life Sciences Initiates Follow-On Behavioral Study to Focus on Gambling Disorder

Jul 18, 2022 02:49AM

Awakn Life Sciences Provides a Business and Corporate Update

Jul 15, 2022 07:30AM

END OF DAY ALERT: Awakn Life Sciences (AWKN: NEO) (AWKNF: OTCQB) Up 15% On 68K SHARES

AGORACOM-Multimedia

Jul 05, 2022 04:00PM

Awakn Life Sciences Receives UK State Funding to Identify Optimal Pathway to Market in UK & US for Its Lead Clinical Development…

Jul 05, 2022 07:42AM